24-26 November 2021
Online
Australia/Sydney timezone

Structural insights into the unique modes of relaxin-binding and tethered-agonist mediated activation of RXFP1 and RXFP2

26 Nov 2021, 14:20
15m
Online

Online

Oral Biomedicine, Life science & Food Science Biomedicine, Life science & Food Science

Speaker

Dr Ashish Sethi (University of Melbourne)

Description

Our poor understanding of the mechanism by which the peptide-hormone H2 relaxin activates its G protein-coupled receptor, RXFP1 and the related receptor RXFP2, has hindered progress in its therapeutic development. Both receptors possess unique ectodomains that comprise of an N-terminal LDLa module joined by a linker to a Leucine Rich Repeat (LRR) domain. Truncation of the N-terminal LDLa module abolishes signalling for both receptors suggesting that the LDLa module is essential for activation and is postulated as a tethered agonist, induced to undergo a conformational change upon H2 relaxin binding.

Here, we use Small Angle X-ray Scattering (SAXS), NMR spectroscopy, cell-based receptor signalling assays to show that it is not the LDLa module, but rather a conserved motif (GDxxGWxxxF), immediately C-terminal to the LDLa, that is the essential tethered agonist. Importantly, this motif associates with the LDLa module of both RXFP1 and RXFP2, in different manners suggesting distinct mechanisms of activation. For RXFP1, the motif is flexible, weakly associates with the LDLa module, and requires H2 relaxin binding to stabilize an active-state conformation. Conversely, the motif in RXFP2 does not possess the same flexibility as it does in RXFP1, and appears to be more structured and closely associated with the LDLa module, forming an essential binding interface for H2 relaxin. H2 relaxin binding to RXFP2 needs both the LDLa module and the motif, distinct to RXFP1 and the tethered agonist activity of the motif is not driven by an induced conformational change in RXFP2, also distinct to RXFP1. These results highlight distinct differences in relaxin mediated activation mechanism of RXFP1 and RXFP2 which will aid drug development targeting these receptors.

Students Only - Are you interested in AINSE student funding No
Which facility did you use for your research Australian Synchrotron
Level of Expertise Early Career <5 Years
Pronouns He/Him
Condition of submission Yes
Presenter Gender Man
Do you wish to take part in the Student Poster Slam No

Primary author

Dr Ashish Sethi (University of Melbourne)

Co-authors

Dr Shoni Bruell Dr Tim Ryan (ANSTO Monash, Calyton) Ms Fei Yan (University of Melbourne) Mr Mohammad Hossein Tanipour (University of Melbourne) Dr Yee-Foong Mok (University of Melbourne) Dr Chris D Joyce (University of Melbourne) Dr Yogesh Khandokar (ANSTO Monash, Clayton) Mr Riley D Metcalfe (University of Melbourne) Dr Michael D.W. Griffin (University of Melbourne) Dr Daniel J. Scott (University of Melbourne) Prof. Mohammad Akhter Hossain (University of Melbourne) Dr Emma J. Petrie (University of Melbourne) Prof. Ross A.D. Bathgate (University of Melbourne) Prof. Paul R. Gooley (University of Melbourne)

Presentation Materials

There are no materials yet.
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

×